Citi Pharma and CCL Pharma execute agreement to manufacture Formulation Products

MG News | July 14, 2021 at 03:22 PM GMT+05:00

0:00

July 14, 2021 (MLN): Citi Pharma Limited (CPHL) and CCL Pharma (Pvt) Limited have executed an agreement to manufacture Formulation Products on their behalf

In a notification to PSX, CPHL informed that this will lead to enhance capacity utilization on the Company’s Formulation segment. Furthermore, this will lead to the addition in Company’s profitability and net margins over the next 2 to 3 years.

Copyright Mettis Link News

Related News

PSX Closing Bell: Hold On, We’re Going Up

Pakistan Hotels Developers seeks 6-month extension in liquidation process

PSX introduces mandatory Shariah disclosure rules

Name	Price/Vol	%Chg/NChg
KSE100	172,400.73 346.40M	0.92% 1570.51
ALLSHR	103,483.96 796.97M	0.55% 561.58
KSE30	52,734.06 184.56M	1.08% 564.57
KMI30	245,565.33 110.97M	1.07% 2605.02
KMIALLSHR	67,233.70 319.67M	0.68% 453.28
BKTi	47,898.10 95.85M	0.98% 462.51
OGTi	33,838.49 13.78M	1.39% 464.88

Symbol	Bid/Ask	High/Low

Name	Last	High/Low	Chg/%Chg
BITCOIN FUTURES	87,825.00	90,115.00 86,915.00	75.00 0.09%
BRENT CRUDE	60.80	62.67 60.56	-1.44 -2.31%
RICHARDS BAY COAL MONTHLY	87.50	0.00 0.00	1.05 1.21%
ROTTERDAM COAL MONTHLY	94.50	0.00 0.00	-0.70 -0.74%
USD RBD PALM OLEIN	1,027.50	1,027.50 1,027.50	0.00 0.00%
CRUDE OIL - WTI	56.93	58.88 56.65	-1.42 -2.43%
SUGAR #11 WORLD	15.17	15.28 15.08	-0.12 -0.78%